Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Tempest Therapeutics, Inc. (TPST) had Return on Equity of 481.09% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-5.24M |
|
-- |
|
-- |
|
$5.25M |
|
$-5.25M |
|
$0.01M |
|
$-5.24M |
|
$-5.24M |
|
$-5.24M |
|
$-5.24M |
|
$-5.24M |
|
$-5.24M |
|
$-5.25M |
|
$-5.19M |
|
15.22M |
|
15.22M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$1.70M |
|
$0.49M |
|
$7.94M |
|
$9.63M |
|
$4.45M |
|
-- |
|
$6.27M |
|
$10.72M |
|
$-1.09M |
|
$-1.09M |
|
$-1.09M |
|
15.98M |
|
| Cash Flow Statement Financials | |
$-10.38M |
|
-- |
|
$3.45M |
|
$8.15M |
|
$1.22M |
|
$-6.93M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
481.09% |
481.10% |
|
-54.44% |
|
481.10% |
|
$-0.07 |
|
$-0.68 |
|
$-0.68 |
|